Showing results (221-230 of 494) with videos related to
Sort By:
Pageof 50
Science Immunology|March 11, 2022
Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell functionRuihan Tang, Nandini Acharya, Ayshwarya Subramanian, et al.Clinical Chemistry|August 21, 2003
Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanomaJolanta Szenajch, Bogdan Jasiński, Agnieszka Synowiec, et al.ESMO Open|October 24, 2020
Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapyDawid Sigorski, Paweł Sobczuk, Małgorzata Osmola, et al.Cancers|June 2, 2021
Chondrosarcoma-from Molecular Pathology to Novel TherapiesAgnieszka E Zając, Sylwia Kopeć, Bartłomiej Szostakowski, et al.American Journal of Therapeutics|January 14, 2014
Treatment algorithms in stage IV melanomaEnrique Espinosa, Jean-Jacques Grob, Reinhard Dummer, et al.Journal of Chemotherapy (Florence, Italy)|August 8, 2024
Long-term outcomes of sequential chemotherapy in epithelioid sarcomaAnna M Czarnecka, Paulina Chmiel, Piotr Błoński, et al.Cancers|December 23, 2023
Diagnostics and Treatment of Extrameningeal Solitary Fibrous TumorsAnna Maria Janik, Anna Terlecka, Mateusz J Spałek, et al.Cancers|June 10, 2023
Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue SarcomasAnna Szumera-Ciećkiewicz, Klaudia Bobak, Mateusz J Spałek, et al.Advances in Medical Sciences|June 20, 2020
Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidenceBożena Cybulska-Stopa, Paweł Rogala, Anna M Czarnecka, et al.Cancers|August 12, 2023
Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical TrialsWeronika Zając, Julia Dróżdż, Weronika Kisielewska, et al.Pageof 50